ADAM12 and nonpapillary renal cell carcinoma: We constructed a predictive model for overall survival by fitting the expression of ADAM12 and other clinical parameters, establishing a nomogram to integrate ADAM12 as a ccRCC biomarker (Figure 4c) with higher points on the nomogram representing worse prognostic factors.